MX2023006551A - Tratamiento de las convulsiones refractarias. - Google Patents
Tratamiento de las convulsiones refractarias.Info
- Publication number
- MX2023006551A MX2023006551A MX2023006551A MX2023006551A MX2023006551A MX 2023006551 A MX2023006551 A MX 2023006551A MX 2023006551 A MX2023006551 A MX 2023006551A MX 2023006551 A MX2023006551 A MX 2023006551A MX 2023006551 A MX2023006551 A MX 2023006551A
- Authority
- MX
- Mexico
- Prior art keywords
- cannabidiol
- treatment
- refractory seizures
- seizures
- refractory
- Prior art date
Links
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 title abstract 3
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 title abstract 3
- 229950011318 cannabidiol Drugs 0.000 title abstract 3
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 title abstract 3
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 title abstract 3
- 206010010904 Convulsion Diseases 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Gasification And Melting Of Waste (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Se proporcionan métodos para tratar las convulsiones refractarias en un sujeto humano, por ejemplo, un niño, que incluyen la administración de una cantidad efectiva de cannabidiol (CBD), por ejemplo, en un gel transdérmico.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063121076P | 2020-12-03 | 2020-12-03 | |
| US202163142820P | 2021-01-28 | 2021-01-28 | |
| PCT/IB2021/061335 WO2022118290A1 (en) | 2020-12-03 | 2021-12-03 | Cannabidiol for the treatment of refractory seizures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023006551A true MX2023006551A (es) | 2023-08-17 |
Family
ID=78844572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023006551A MX2023006551A (es) | 2020-12-03 | 2021-12-03 | Tratamiento de las convulsiones refractarias. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240009210A1 (es) |
| EP (1) | EP4255402A1 (es) |
| JP (1) | JP2023552390A (es) |
| KR (1) | KR20230113622A (es) |
| AU (1) | AU2021392090A1 (es) |
| CA (1) | CA3200996A1 (es) |
| IL (1) | IL303388A (es) |
| MX (1) | MX2023006551A (es) |
| WO (1) | WO2022118290A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12016829B2 (en) | 2019-10-11 | 2024-06-25 | Pike Therapeutics Inc. | Pharmaceutical composition and method for treating seizure disorders |
| CN117479930A (zh) * | 2021-04-08 | 2024-01-30 | 长矛治疗股份有限公司 | 用于治疗癫痫发作病症的药物组合物和方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8449908B2 (en) | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
| EP2424525A1 (en) | 2009-04-28 | 2012-03-07 | AllTranz Inc. | Formulations of cannabidiol and methods of using the same |
| EP3681525A4 (en) * | 2017-09-15 | 2020-09-02 | Zelda Therapeutics Operations Pty Ltd | COMPOSITION AND METHOD OF PROCESSING AUTISM |
| HRP20220277T1 (hr) * | 2017-09-28 | 2022-05-13 | Zynerba Pharmaceuticals, Inc. | Liječenje fragilnog x sindroma i autizma kanabidiolom |
| US20210196669A1 (en) * | 2018-05-24 | 2021-07-01 | To Pharmaceuticals Llc | Cannabis-based compositions for the treatment of autistic spectrum disorders |
| WO2021055499A1 (en) * | 2019-09-17 | 2021-03-25 | Zynerba Pharmaceuticals, Inc. | Treatment of behavioral impairment in developmental and epileptic encephalopathy |
-
2021
- 2021-12-03 IL IL303388A patent/IL303388A/en unknown
- 2021-12-03 CA CA3200996A patent/CA3200996A1/en active Pending
- 2021-12-03 JP JP2023533923A patent/JP2023552390A/ja active Pending
- 2021-12-03 WO PCT/IB2021/061335 patent/WO2022118290A1/en active Application Filing
- 2021-12-03 KR KR1020237022399A patent/KR20230113622A/ko unknown
- 2021-12-03 AU AU2021392090A patent/AU2021392090A1/en active Pending
- 2021-12-03 US US18/255,816 patent/US20240009210A1/en active Pending
- 2021-12-03 EP EP21824054.7A patent/EP4255402A1/en active Pending
- 2021-12-03 MX MX2023006551A patent/MX2023006551A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230113622A (ko) | 2023-07-31 |
| IL303388A (en) | 2023-08-01 |
| WO2022118290A1 (en) | 2022-06-09 |
| AU2021392090A1 (en) | 2023-07-06 |
| EP4255402A1 (en) | 2023-10-11 |
| JP2023552390A (ja) | 2023-12-15 |
| CA3200996A1 (en) | 2022-06-09 |
| US20240009210A1 (en) | 2024-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2018022668A3 (en) | NEUROMODULATORY COMPOSITIONS AND ASSOCIATED METHODS OF TREATING CANCER | |
| MX2023006551A (es) | Tratamiento de las convulsiones refractarias. | |
| MX2020005547A (es) | Moduladores de la actividad del complemento. | |
| MX2023007212A (es) | Formulaciones de pulverizacion de epinefrina. | |
| MX2020008680A (es) | Terapia de combinacion con apilimod y agentes glutamatergicos. | |
| JOP20220061A1 (ar) | علاج الضعف السلوكي في الاعتلال الدماغي النموي والصرعي | |
| MX2019013862A (es) | Terapia de combinacion. | |
| MX2021010173A (es) | Compuestos con actividad inductora de ferroptosis y métodos de uso. | |
| MX2020011817A (es) | Metodos para tratar el linfoma. | |
| WO2012086991A3 (ko) | 광 치료장치 및 이의 제어방법 | |
| MX2020001727A (es) | Terapia de combinacion. | |
| MX2023004156A (es) | Terapia combinada para el tratamiento del cancer. | |
| WO2018209022A3 (en) | Methods of treating neuropsychiatric disorders | |
| EA201992658A1 (ru) | Методы лечения рекуррентной глиобластомы (rgbm) | |
| JOP20200031A1 (ar) | طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة | |
| ZA202300875B (en) | Kat6 inhibitor methods and combinations for cancer treatment | |
| MX2022006853A (es) | Macrociclos para uso en el tratamiento de enfermedades. | |
| EA202193276A1 (ru) | Способы лечения холангиокарциномы | |
| MX2020008881A (es) | Métodos de tratamiento contra el cáncer que comprenden inhibidores de chk1. | |
| MX2022011888A (es) | Tratamiento de trastornos respiratorios. | |
| MX2021011529A (es) | Chiauranib para el tratamiento de cáncer de pulmón microcítico. | |
| MX2017013666A (es) | Terapia de combinacion de agente anti-fuctactico y agente de inmunoterapia y composiciones para el tratamiento de cancer. | |
| EA202190226A1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ HFpEF С ИСПОЛЬЗОВАНИЕМ ДАПАГЛИФЛОЗИНА И СОДЕРЖАЩИХ ЕГО КОМПОЗИЦИЙ | |
| MX2023011790A (es) | Terapias combinadas para tratar el cancer. | |
| WO2020061067A3 (en) | Compositions and methods for treating bone injury |